Development of a Mobile Health Intervention for Electronic Cigarette Use Among Young Adults
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-26
SponsorUniversity of Chicago
About this trial
Electronic Nicotine Delivery Systems (ENDS) use remains prevalent among young adults, and many have high interest in quitting, yet research on effective intervention is lacking. A mobile health (mHealth) intervention that translates effective smoking cessation materials and pharmacotherapy may be a promising avenue for intervention. The initial phase of the proposed study uses a pilot study to evaluate a novel mHealth intervention for young adult ENDS and dual product (ENDS and combustible cigarette) users.
Eligibility criteria
Qualifiers
Age 18-26 years old, ability to understand the English language, willing and able to provide informed consent
Current ENDS user (at least 4 out of 7 days per week of use for the past one month); for focus groups, at least half of participants will report current cigarette smoking (at least 1 cigarette per day on at least 1 day per week in the past month)
Report interest in quitting or reducing ENDS (at least 6/10 scale in interest of quitting or reducing
Does not currently (in past one year) meet criteria for major psychiatric disorder including severe alcohol or substance use disorder (excluding tobacco use disorder), schizophrenia, bipolar disorder, and obsessive compulsive disorder
Disqualifiers
Does not own a mobile phone or is unwilling to receive text messages to their device
No interest in quitting or reducing use of ENDS
Uses electronic cigarettes less than 4 days per week in the past month
Reports past-year serious psychiatric illness, including severe alcohol or substance use disorder (excluding tobacco use disorder), schizophrenia, bipolar disorder, and obsessive compulsive disorder
Trial design
Treatments tested in this trial
- EQUIP
- Standard Care
Treatment groups
46 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov